BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20372809)

  • 1. Longdan Xiegan Tang has immunomodulatory effects on CD4+CD25+ T cells and attenuates pathological signs in MRL/lpr mice.
    Lee TY; Chang HH
    Int J Mol Med; 2010 May; 25(5):677-85. PubMed ID: 20372809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory effects of Longdan Xiegan Tang on CD4+/CD8+ T cells and associated inflammatory cytokines in rats with experimental autoimmune uveitis.
    Tang K; Guo D; Zhang L; Guo J; Zheng F; Si J; Bi H
    Mol Med Rep; 2016 Sep; 14(3):2746-54. PubMed ID: 27485320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymus-dependent effects of a traditional Chinese medicine, ren-shen-yang-rong-tang (Japanese name; Ninjin-youei-to), in autoimmune MRI/MP-lpr/lpr mice.
    Nakai S; Kawakita T; Nagasawa H; Himeno K; Nomoto K
    Int J Immunopharmacol; 1996 Apr; 18(4):271-9. PubMed ID: 8894807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE; Ke B; Hollmann TJ; Wetsel RA; Lan HY; Braun MC
    J Am Soc Nephrol; 2005 Dec; 16(12):3572-82. PubMed ID: 16207826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
    Drappa J; Brot N; Elkon KB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/lpr mice.
    Ito T; Seo N; Yagi H; Ohtani T; Tokura Y; Takigawa M; Furukawa F
    J Dermatol Sci; 2002 Apr; 28(3):198-210. PubMed ID: 11912007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
    Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 regulates murine lupus.
    Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
    J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice.
    Chu M; Tam LS; Zhu J; Jiao D; Liu H; Cai Z; Dong J; Kai Lam CW; Wong CK
    Immunobiology; 2017 Mar; 222(3):483-493. PubMed ID: 27769564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
    Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
    Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4
    Dai R; Heid B; Xu X; Xie H; Reilly CM; Ahmed SA
    BMC Immunol; 2020 Jul; 21(1):41. PubMed ID: 32646370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1).
    Sugiyama N; Nakashima H; Yoshimura T; Sadanaga A; Shimizu S; Masutani K; Igawa T; Akahoshi M; Miyake K; Takeda A; Yoshimura A; Hamano S; Yoshida H
    Ann Rheum Dis; 2008 Oct; 67(10):1461-7. PubMed ID: 18094002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulating effect of a traditional Japanese medicine, hachimi-jio-gan (ba-wei-di-huang-wan), on Th1 predominance in autoimmune MRL/MP-lpr/lpr mice.
    Furuya Y; Kawakita T; Nomoto K
    Int Immunopharmacol; 2001 Mar; 1(3):551-9. PubMed ID: 11367538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.